Document is current
Any future updates will be listed below
-
Authors
Wimmer, Kerstin
Sachet, Monika
Ramos, Cristiano
Frantal, Sophie
Birnleitner, Hanna
Brostjan, Christine
Exner, Ruth
Filipits, Martin
Bago-Horvath, Zsuzsanna
Rudas, Margaretha
Bartsch, Rupert
Gnant, Michael
Singer, Christian F.
Balic, Marija
Egle, Daniel
Oehler, Rudolf https://orcid.org/0000-0003-2891-7155
Fitzal, Florian
-
Funding
Funding for this research was provided by:
Austrian Breast & Colorectal Study Group
- License Information
-
More Information
Article History
Received: 17 May 2023
Accepted: 29 October 2023
First Online: 14 November 2023
Declarations
:
: The randomized, prospective ABCSG-34 (EudraCT Number: 2011–004822-85) trial was conducted by the Austrian Breast Cancer and Colorectal Study Group (ABCSG) and was a registered clinical trial. The study has been approved by the responsible ethics committee EC Medical University of Vienna on 12Dec2011. The trial was conducted according to the guidelines of the Declaration of Helsinki and were carried out in accordance with the guidelines for Good Clinical Practice. All patients provided signed informed consent.
: All authors have completed the declaration of competing interests form.
